Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Subhashini Jagu

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Plos One|November 10, 2011
Capsomer vaccines protect mice from vaginal challenge with human papillomavirusWai-Hong Wu, Elizabeth Gersch, Kihyuck Kwak, et al.
Journal of the National Cancer Institute|May 28, 2009
Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccinesSubhashini Jagu, Balasubramanyam Karanam, Ratish Gambhira, et al.
Pediatric Blood & Cancer|October 27, 2023
Childhood cancer data initiative: Status reportSubhashini Jagu, Elaine R Mardis, Mary F Wedekind, et al.
The American Journal of Pathology|December 20, 2008
Expression pattern and subcellular localization of human papillomavirus minor capsid protein L2Zhenhua Lin, Anna V Yemelyanova, Ratish Gambhira, et al.
Virology|September 17, 2011
A multimeric L2 vaccine for prevention of animal papillomavirus infectionsSubhashini Jagu, Nicole Malandro, Kihyuck Kwak, et al.
Vaccine|December 20, 2008
Vaccination with HPV16 L2E6E7 fusion protein in GPI-0100 adjuvant elicits protective humoral and cell-mediated immunityBalasubramanyam Karanam, Ratish Gambhira, Shiwen Peng, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2008
Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2Hannah H Alphs, Ratish Gambhira, Balasubramanyam Karanam, et al.
Journal of Virology|October 12, 2007
A protective and broadly cross-neutralizing epitope of human papillomavirus L2Ratish Gambhira, Balasubramanyam Karanam, Subhashini Jagu, et al.
Vaccine|September 19, 2015
Durable immunity to oncogenic human papillomaviruses elicited by adjuvanted recombinant Adeno-associated virus-like particle immunogen displaying L2 17-36 epitopesSubhashini Jagu, Balusubramanyam Karanam, Joshua W Wang, et al.
Plos One|July 8, 2014
Measurement of neutralizing serum antibodies of patients vaccinated with human papillomavirus L1 or L2-based immunogens using furin-cleaved HPV PseudovirionsJoshua W Wang, Subhashini Jagu, Chenguang Wang, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Plos One|November 10, 2011
Capsomer vaccines protect mice from vaginal challenge with human papillomavirusWai-Hong Wu, Elizabeth Gersch, Kihyuck Kwak, et al.
Journal of the National Cancer Institute|May 28, 2009
Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccinesSubhashini Jagu, Balasubramanyam Karanam, Ratish Gambhira, et al.
Pediatric Blood & Cancer|October 27, 2023
Childhood cancer data initiative: Status reportSubhashini Jagu, Elaine R Mardis, Mary F Wedekind, et al.
The American Journal of Pathology|December 20, 2008
Expression pattern and subcellular localization of human papillomavirus minor capsid protein L2Zhenhua Lin, Anna V Yemelyanova, Ratish Gambhira, et al.
Virology|September 17, 2011
A multimeric L2 vaccine for prevention of animal papillomavirus infectionsSubhashini Jagu, Nicole Malandro, Kihyuck Kwak, et al.
Vaccine|December 20, 2008
Vaccination with HPV16 L2E6E7 fusion protein in GPI-0100 adjuvant elicits protective humoral and cell-mediated immunityBalasubramanyam Karanam, Ratish Gambhira, Shiwen Peng, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2008
Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2Hannah H Alphs, Ratish Gambhira, Balasubramanyam Karanam, et al.
Journal of Virology|October 12, 2007
A protective and broadly cross-neutralizing epitope of human papillomavirus L2Ratish Gambhira, Balasubramanyam Karanam, Subhashini Jagu, et al.
Vaccine|September 19, 2015
Durable immunity to oncogenic human papillomaviruses elicited by adjuvanted recombinant Adeno-associated virus-like particle immunogen displaying L2 17-36 epitopesSubhashini Jagu, Balusubramanyam Karanam, Joshua W Wang, et al.
Plos One|July 8, 2014
Measurement of neutralizing serum antibodies of patients vaccinated with human papillomavirus L1 or L2-based immunogens using furin-cleaved HPV PseudovirionsJoshua W Wang, Subhashini Jagu, Chenguang Wang, et al.
Pageof 4